Results 181 to 190 of about 31,515 (266)

Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients

, 2021
Yael Bogler, Anat Stern, Yiqi Su, Yeon Joo Lee, Susan K. Seo, Brian C. Shaffer, Miguel‐Angel Perales, Genovefa A. Papanicolaou, Dionysios Neofytos   +8 more
openalex   +2 more sources

Epidemiology and Risk Factors for Invasive Fungal Infections in Pancreas Transplant in the Absence of Postoperative Antifungal Prophylaxis. [PDF]

Open Forum Infect Dis, 2023
Zachary J, Chen JM, Sharfuddin A, Yaqub M, Lutz A, Powelson J, Fridell JA, Barros N.   +7 more
europepmc   +1 more source

1301. Breakthrough Invasive Fungal Infections based on CYP2C19 Levels in Patients Who were on Voriconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) undergoing Induction Chemotherapy [PDF]

, 2020
Hareesh v Singam, Yanina Pasikhova, Rod Quilitz, John N. Greene, Aliyah Baluch   +4 more
openalex   +1 more source

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen [PDF]

, 2017
Abboud, Camille N, Ali, Alaa M, Cashen, Amanda F, DiPersio, John F, Fehniger, Todd A, Gao, Feng, Ghobadi, Armin, Jacoby, Meagan A, Oh, Stephen T, Pusic, Iskra, Romee, Rizwan, Schroeder, Mark A, Stockerl-Goldstein, Keith E, Uy, Geoffrey L, Vij, Ravi, Wartman, Lukas D, Weisel, Daniel, Welch, John S, Westervelt, Peter   +18 more
core   +2 more sources

Fungal endocarditis in children and antifungal prophylaxis

Kardiologia Polska, 2020
Radoslaw, Jaworski, Andrzej, Kansy, Bohdan, Maruszewski   +2 more
openaire   +3 more sources

Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study

, 2020
Prithviraj Bose, David McCue, Sebastian Wurster, Nathan P. Wiederhold, Marina Konopleva, Tapan M. Kadia, Gautam Borthakur, Farhad Ravandi, Lucia Masárová, Koichi Takahashi, Zeev Estrov, Musa Yılmaz, Naval Daver, Naveen Pemmaraju, Kiran Naqvi, Caitlin R. Rausch, Kayleigh Marx, Wei Qiao, Xuelin Huang, Carol Bivins, Sherry Pierce, Hagop M. Kantarjian, Dimitrios P. Kontoyiannis   +22 more
openalex   +2 more sources

Efficacy of different durations of antifungal prophylaxis with nebulized amphotericin B after lung transplantation: a retrospective cohort study. [PDF]

J Thorac Dis, 2023
Ju C, Lian Q, Wang X, Wang L, Zhang J, Cai Y, Xu X, Chen R, He J.   +8 more
europepmc   +1 more source

DP042 | IMPACT OF ANTIFUNGAL PROPHYLAXIS ON TRANSPLANT-RELATED MORTALITY IN MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): A PROSPECTIVE EXPERIENCE FROM A SINGLE TRANSPLANT PROGRAM

Haematologica
Background In the allogeneic HSCT, the incidence of Invasive Fungal Disease is 7-9% with high rate of mortality. Although the antifungal prophylaxis is crucial, the role of anidulafungin is unknown.
A. Carobene, M. Pedata, M. Celentano, T. Ascione, C. Riccardi, S. Marotta, S. Leone, I. Migliaccio, C. Luise, U. De Martino, V. Oliva, S.M. Muggianu, M. Boccola, D. Buonanno, C. Falco, L. Altomare, A. Zuccarelli, M. Toriello, R. Penta, and A. Picardi   +19 more
doaj  

Secondary Antifungal Prophylaxis in Hematological Malignancy Patients with Previous Invasive Fungal Disease: A Retrospective Analysis

, 2014
Mingjuan Liu, Yan Li, Yongqing Zhang, Xiaoli Zhao, Bing Zhai, Qingyi Zhang, Lijun Wang, Yu Zhao, Honghua Li, Quanshun Wang, Chunji Gao, Wenrong Huang, Li Yu   +12 more
openalex   +2 more sources

Fungal colonization and CLAD in lung transplant recipients: Implications for antifungal prophylaxis and graft survival. [PDF]

JHLT Open
Dhanani Z, Albaba I, Anjum F.
europepmc   +1 more source